TickerFacts.

Atea Pharmaceuticals, Inc. (AVIR): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.94M
Year ended 2022-12-31
n/m
3-year compound annual growth
2018-12-31: $12.0K2019-12-31: $2.0K2020-12-31: $26.0K2021-12-31: $4.0K2022-12-31: $1.94M$1.94M
2018-12-31 Capital Expenditures (USD) 2022-12-31
Period endedCapital ExpendituresChange YoYSource filing
2022-12-31$1.94Mn/m2024-02-28, From 2022-01-01
2021-12-31$4.0K-84.6%2023-02-28, From 2021-01-01
2020-12-31$26.0Kn/m2023-02-28, From 2020-01-01
2019-12-31$2.0K-83.3%2022-02-28, From 2019-01-01
2018-12-31$12.0Kn/a2021-03-30, From 2018-01-01